ARCHIVES

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 46 | November 14, 1975

Download PDF Visit The Full Archive

Related Articles

Switch T CD-Rom To Save PDQ $1 Mil. Over Five Years

September 14, 1990

Prognostic Factors Don’t Explain Better Prostate Cancer Survival In Most Asian Men

August 31, 2007

NCI’s Otis Brawley Named Professor At Emory, Associate Director, Cancer Control, At Winship.

April 20, 2001

NIH director; Targets Increases Favor Established Researchers

May 9, 1997

Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer

February 26, 2010

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

May 27, 2011